Literature DB >> 20154667

Garbled messages and corrupted translations.

Tilman Schneider-Poetsch1, Takeo Usui, Daisuke Kaida, Minoru Yoshida.   

Abstract

Following transcription, genomic information begins a long journey toward translation of its nucleotide sequence into the amino acids of a protein. In eukaryotes, synthesized pre-mRNAs become processed to mature mRNAs by 5'-end capping, splicing, 3'-end cleavage and polyadenylation in the nucleus, before being scrutinized for premature stop codons. Each step requires high precision and control to ensure that an intact and readable message is exported to the cytoplasm before finally becoming translated. Two important aspects of these processes are accurately managed by ribonucleoprotein machineries-the spliceosome and the ribosome. Recently, several natural products targeting these macromolecular assemblies have been reported. For the first time in eukaryotes, these molecules allow chemical disruption and dissection of the sophisticated machinery that regulates post-transcriptional events. Beyond their great potential as bioprobes for investigating mRNA regulation and protein synthesis, these compounds also show promise in opening new therapeutic approaches.

Year:  2010        PMID: 20154667     DOI: 10.1038/nchembio.326

Source DB:  PubMed          Journal:  Nat Chem Biol        ISSN: 1552-4450            Impact factor:   15.040


  94 in total

1.  Structural basis of the ribosomal machinery for peptide bond formation, translocation, and nascent chain progression.

Authors:  Anat Bashan; Ilana Agmon; Raz Zarivach; Frank Schluenzen; Joerg Harms; Rita Berisio; Heike Bartels; Francois Franceschi; Tamar Auerbach; Harly A S Hansen; Elizaveta Kossoy; Maggie Kessler; Ada Yonath
Journal:  Mol Cell       Date:  2003-01       Impact factor: 17.970

Review 2.  Alternative splicing: new insights from global analyses.

Authors:  Benjamin J Blencowe
Journal:  Cell       Date:  2006-07-14       Impact factor: 41.582

3.  Selective modification of alternative splicing by indole derivatives that target serine-arginine-rich protein splicing factors.

Authors:  Johann Soret; Nadia Bakkour; Sophie Maire; Sébastien Durand; Latifa Zekri; Mathieu Gabut; Weronika Fic; Gilles Divita; Christian Rivalle; Daniel Dauzonne; Chi Hung Nguyen; Philippe Jeanteur; Jamal Tazi
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-06       Impact factor: 11.205

4.  Stalling of spliceosome assembly at distinct stages by small-molecule inhibitors of protein acetylation and deacetylation.

Authors:  Andreas N Kuhn; Maria A van Santen; Andreas Schwienhorst; Henning Urlaub; Reinhard Lührmann
Journal:  RNA       Date:  2008-11-24       Impact factor: 4.942

5.  13-Deoxytedanolide, a marine sponge-derived antitumor macrolide, binds to the 60S large ribosomal subunit.

Authors:  Shinichi Nishimura; Shigeki Matsunaga; Minoru Yoshida; Hiroshi Hirota; Shigeyuki Yokoyama; Nobuhiro Fusetani
Journal:  Bioorg Med Chem       Date:  2005-01-17       Impact factor: 3.641

6.  Modulation of the helicase activity of eIF4A by eIF4B, eIF4H, and eIF4F.

Authors:  G W Rogers; N J Richter; W F Lima; W C Merrick
Journal:  J Biol Chem       Date:  2001-06-19       Impact factor: 5.157

7.  An eIF4AIII-containing complex required for mRNA localization and nonsense-mediated mRNA decay.

Authors:  Isabel M Palacios; David Gatfield; Daniel St Johnston; Elisa Izaurralde
Journal:  Nature       Date:  2004-02-19       Impact factor: 49.962

8.  U2504 determines the species specificity of the A-site cleft antibiotics: the structures of tiamulin, homoharringtonine, and bruceantin bound to the ribosome.

Authors:  Güliz Gürel; Gregor Blaha; Peter B Moore; Thomas A Steitz
Journal:  J Mol Biol       Date:  2009-04-09       Impact factor: 5.469

9.  Splicing factor SF3b as a target of the antitumor natural product pladienolide.

Authors:  Yoshihiko Kotake; Koji Sagane; Takashi Owa; Yuko Mimori-Kiyosue; Hajime Shimizu; Mai Uesugi; Yasushi Ishihama; Masao Iwata; Yoshiharu Mizui
Journal:  Nat Chem Biol       Date:  2007-07-22       Impact factor: 15.040

10.  The biflavonoid isoginkgetin is a general inhibitor of Pre-mRNA splicing.

Authors:  Kristine O'Brien; Arianne J Matlin; April M Lowell; Melissa J Moore
Journal:  J Biol Chem       Date:  2008-09-30       Impact factor: 5.157

View more
  5 in total

1.  Lactimidomycin is a broad-spectrum inhibitor of dengue and other RNA viruses.

Authors:  Margot Carocci; Priscilla L Yang
Journal:  Antiviral Res       Date:  2016-02-10       Impact factor: 5.970

2.  Splicing inhibition decreases phosphorylation level of Ser2 in Pol II CTD.

Authors:  Mitsunori Koga; Megumi Hayashi; Daisuke Kaida
Journal:  Nucleic Acids Res       Date:  2015-07-21       Impact factor: 16.971

3.  An siRNA Screen Identifies the U2 snRNP Spliceosome as a Host Restriction Factor for Recombinant Adeno-associated Viruses.

Authors:  Claire A Schreiber; Toshie Sakuma; Yoshihiro Izumiya; Sara J Holditch; Raymond D Hickey; Robert K Bressin; Upamanyu Basu; Kazunori Koide; Aravind Asokan; Yasuhiro Ikeda
Journal:  PLoS Pathog       Date:  2015-08-05       Impact factor: 6.823

4.  Splicing controls the ubiquitin response during DNA double-strand break repair.

Authors:  C Pederiva; S Böhm; A Julner; M Farnebo
Journal:  Cell Death Differ       Date:  2016-06-17       Impact factor: 15.828

Review 5.  Microbial and Natural Metabolites That Inhibit Splicing: A Powerful Alternative for Cancer Treatment.

Authors:  Nancy Martínez-Montiel; Nora Hilda Rosas-Murrieta; Mónica Martínez-Montiel; Mayra Patricia Gaspariano-Cholula; Rebeca D Martínez-Contreras
Journal:  Biomed Res Int       Date:  2016-08-16       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.